Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesBiomarkers in Pediatric ARDS: Future DirectionsA Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress SyndromeMicroarray meta-analysis identifies acute lung injury biomarkers in donor lungs that predict development of primary graft failure in recipientsThe HMGB1-RAGE Inflammatory Pathway: Implications for Brain Injury-Induced Pulmonary DysfunctionVitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injurySystemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityAcute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling.Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injuryRole of diabetes in the development of acute respiratory distress syndrome.Accumulation of advanced glycation end (AGEs) products in intensive care patients: an observational, prospective study.The receptor for advanced glycation end products (RAGE) and the lung.Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.Beyond mortality: future clinical research in acute lung injury.Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in miceContribution of damage-associated molecular patterns to transfusion-related acute lung injury in cardiac surgery.Biomarkers of acute lung injury: worth their salt?The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure.Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.Alveolar fluid clearance is faster in women with acute lung injury compared to men.Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.Plasma levels of sRAGE, loss of aeration and weaning failure in ICU patients: a prospective observational multicenter studyProteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.Soluble isoform of the receptor for advanced glycation end products as a biomarker for postoperative respiratory failure after cardiac surgeryMesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndromeThe acute respiratory distress syndrome: pathogenesis and treatmentAssociations between maternal and infant morbidities and sRAGE within the first week of life in extremely preterm infants.Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgeryAcute lung injury: epidemiology, pathogenesis, and treatment.Biomarkers in acute lung injury--marking forward progress.Risk of acute lung injury/acute respiratory distress syndrome in critically ill adult patients with pre-existing diabetes: a meta-analysis.Acute respiratory distress syndrome: A clinical reviewPolymorphisms in key pulmonary inflammatory pathways and the development of acute respiratory distress syndrome.Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies.
P2860
Q21285070-D76A5464-56D4-4D74-8704-F84363E3EC47Q26744577-9678108A-3F11-4027-926F-42BE2BC5BE4FQ26765351-4F40F719-822C-406A-BD53-0C313BF2D036Q27318057-2A07E3A9-40A0-41A0-B00B-9B150E9DC693Q28085089-FD8B6A08-90B9-4FAA-8A6F-B20016FDC351Q28647828-42CEE26E-10AA-4AF1-889D-670033CAF64EQ28727445-1C68C838-09F0-4AB0-8F3B-B14C0279E610Q28728578-4F60DA29-3E54-4CA1-8D23-3920F52E032EQ30422075-F12F0F0B-6E51-4F62-9717-EF048CEEF20BQ30826105-B1BB5B8F-42C5-4948-9126-DB99C707C4C3Q31143915-72965E9D-93CE-4483-810A-9EA1795993A3Q33512670-A58A529A-E1F6-4989-BC8F-EC6711AD965DQ33555078-216D4CF7-2268-4B34-8564-B61D6C319001Q33586749-1066934C-9272-44E6-AD96-332104304E72Q33633330-BF3E25B2-132C-4C83-A735-F0F48A47B6F4Q33750995-E74DD89E-DAE8-4EB0-A55B-190870D70CA6Q33808300-8531E405-FB4B-46CB-BBC4-31FADE3AE331Q33868624-0DD0A257-4B12-4CFE-A902-0F7A6725B0EDQ33918403-98198123-1DB0-4D82-BD56-A0B5E8249BD9Q33953460-628173EA-9017-476F-A057-F6A0CEFA42E6Q34094906-4F4F3027-5E06-4190-81A7-C684DE2339BCQ34299206-4CE8BBC7-C9AE-47BD-8819-544BC17E882AQ34302302-D1B65667-05FD-4942-9DBF-18C5AAC01FC0Q34316213-2E23EEA2-BADC-4A1F-8433-4CFEC958CB5FQ34564061-A1867ACA-8EAC-413C-9B7B-8D73FC0F9EB5Q34712791-1FFF51C0-63B3-4E71-B04B-C9C2FF698CF6Q34749439-8B1BA4BB-4700-4490-B718-9E696AF51C5FQ34784921-009936B1-DD05-4E15-BA21-D36FD8967D55Q34875734-BBA40D17-6AF5-4716-9CCA-1C5AC0A03CD0Q34979725-0B50285D-BA33-47B7-B4B0-DB16BE72593AQ35017280-468E99AC-05D8-4314-AC2E-A768290ED624Q35025114-88353B82-EDE2-495D-8FCE-CD9D1444C370Q35064231-4DCCAD4D-3CFF-4FEC-B4B1-BC15ACA782C5Q35068413-EF13E9DA-7ECC-4056-A0FD-5B1415516148Q35097126-6EB57695-3ED3-4C87-8DA8-6995D6019F44Q35100674-98C8DD1C-FF6C-4956-A920-76ADC8C49B59Q35109032-C699BACF-2D11-46CD-A4D8-50FBDD873D28Q35412409-E90E6ADF-C656-493B-9DCF-E33A714610F8Q35523593-00431EE1-5EBA-439D-A745-829D7D7643C6Q35672843-91D053BC-84CD-46CD-9B8D-9AA9457560CE
P2860
Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@en
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@nl
type
label
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@en
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@nl
prefLabel
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@en
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@nl
P2093
P2860
P356
P1433
P1476
Plasma receptor for advanced g ...... outcomes in acute lung injury.
@en
P2093
B T Thompson
C S Calfee
M A Matthay
M D Eisner
N Wickersham
NHLBI ARDS Network
P E Parsons
P2860
P304
P356
10.1136/THX.2008.095588
P407
P577
2008-06-19T00:00:00Z